MetaCap

MBX Biosciences Statistics

NASDAQ: MBXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

49.55-3.86 (-7.23%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

MBX Biosciences by the numbers

MBX Biosciences has a market capitalization of $2.46 billion based on 49.66M shares outstanding. With trailing EPS of $-3.03, MBX Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.7% below its 50-day average and 6.1% above its 200-day average.

Average daily trading volume is 532.80K shares, or about $26.4 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

MBX valuation vs. peer median

MBX compared with the median of 8 peer companies
MetricMBXPeer medianDifference
Market cap$2.46B$2.33B+6%
Avg. volume532.80K962.46K-45%

Peer median across 8 companies: IDYA, XNCR, PBH, HCM, ZLAB, RCUS, PHVS, PRGO.

Valuation

Price and trading

Previous close
53.41
Open
52.92
Day range
49.36 – 54.43
52-week range
26.14 – 72.64
52-week change
+82.98%
Beta
—
Volume
581.89K

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
2.46B
Forward Pe
-11.38
Eps
-3.03
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
72.64
Week52 Low
26.14
Avg Volume
532.80K
Shares Outstanding
49.66M
Ma50
54.88
Ma200
46.69
Earnings Date
Nov 12, 2026
Pct From52w High
-31.79%
Pct From52w Low
89.56%

Related